Sonablate® 500
1. The Sonablate® 500 is approved in many countries outside the U.S. as an image-guided acoustic ablation device developed by Focus Surgery, Inc. (Indianapolis , U.S.A.) for prostate disease therapy.
2. The technology behind the device originated at the Indiana University School of Medicine in Indianapolis in the 1970s. It was further developed in leading research centers across the globe.
3. In 2001, The Sonablate® 500 received its CE Mark for European distribution and its MHW approval for Japan. It is also approved for use in Canada, India, China, Australia, Japan, Costa Rica, South Africa and the Caribbean.
4. Recent studies in Europe have also shown promising results one year following treatment with a lower incidence of erectile dysfunction and urinary incontinence than reported in studies of other therapies.
5. In countries where it is approved, the Sonablate® 500 allows a trained urologist to visualize the prostate and plan and monitor the therapy in real time, ensuring maximum precision, flexibility, safety, and control for the clinician.